SPONSOR
Jiangsu vcare pharmaceutical technology co., LTD
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3
NCT07172347 Phase 2
Recruiting
Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
Non-segmental Vitiligo
NCT07172360 Phase 3
Recruiting
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Active Ankylosing Spondylitis